Raman Nanotheranostics (RaNT) envisions a revolutionary all-in-one approach to disease diagnosis and cancer treatment, developing a new technology that wields the light enhancing powers of gold nanostructures.
RaNT is being designed to locate and identify multiple different cancer targets in real-time, allowing for immediate, informed treatment decisions, and the delivery of on-the-spot therapy.
What’s more, RaNT aims to do all this non-invasively following a simple injection!
We are developing the capability to detect from anywhere in the body, reducing the need for tissue biopsies and aggressive sampling, and we are advancing a new non-surgical treatment solution.
Improved quality-of-life is at the heart of the project.
RaNT strives to achieve a better prognosis for patients, promising faster, more accurate diagnoses.
It aims to provide a rapid therapeutic response with less potential for overtreatment, reoperation, and crucially, a reduced chance of recurrence.
RaNT is a collaborative research programme led by scientists at the University of Exeter with partners at the University of Cambridge, the UCL School of Pharmacy, and the Science and Technology Facilities Council (STFC) Rutherford Appleton Labs.
Funded by a £5.7 million grant from the Engineering and Physical Sciences Research Council (EPSRC). This is a 5 year project (2018-2023) currently at the laboratory stage working towards a functioning proof of principle.